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W O types of interaction are integrated in a
biological system between the cells of the
microbic invaders, on the one hand, and the drug
that is introduced into the system to combat them,
on the other. The first type is basically physical
and the second chemical. Illustrative of the for
mer are such phenomena as osmosis, diffusion,
hydration, dehydration, solution, adsorption, cor
rosion and altered surface tension; while illus
trative of the latter are such phenomena as
precipitation, absorption, oxidation, reduction, fu
sion and disintegration. In a general sense the
action of alkaloids simulates the former sort of
interaction in which the drug bombards and after
performing its action, is then released and elimi
nated unchanged; whereas the action of glyco
sides simulates the latter. In this instance chemical
interaction between the constituent molecules oc
curs and as a consequence one or more of the
above-named chemical changes takes place. Disin
tegration of the drug molecule and arrest or death
of the invading cells with a sparing of the body
cells result if the remedial drug is efficacious as it
would be at therapeutic levels; while destruction
of the cells of the host may ensue at toxic levels.
Until the time of Schmiedeberg, confusion
reigned with regard to an appreciation of these
fundamental emphases; and, as a result the for
tunes o f pharmacology rested insecurely in the
empirical hands of the clinician. As Henri Berg
son, in his "Creative Evolution" said of the phi
losopher that he can focus upon and clarify but
one of the manifold facets of the cosmic jewel in
his lifetime so it seems in science that only in
exceptional cases are more vistas than one, of the
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unknown at the periphery of nature’s known, ex
plored by any single investigator. With nothing
more than dim adumbrations of the chemical ap
proach men like Schmiedeberg, Bernard and
Cushny have traversed the first pathway and ex
ploited its rich resources until Pasteur, Koch and
Lister came upon the scene bringing with them
instruments that were right then being hammered
out on the anvil of a dawning creative chemistry.
The chemical approach to pharmaco-dynamic en
terprises came to full-bloom in the brilliant re
searches of Ehrlich; and chemotherapy has since
become an intriguing adventure in the study of
the drug-host-invader complex. Ehrlich directed
his attack on trypanosomiasis with the arsenicals.
Then came Sazerac and Levaditi in their experi
ments with bismuth on the trepanema pallidium.
The theoretical basis of Ehrlich’s historic achieve
ments is quite well known to students of im
munology. Equipped with certain structural con
figurations complimentary to those of the invading
micro-organism the drug in question is supposed
to attach itself to the invader acting thereby as
substitute for the cells of the host; and by means
of this selective chemical affinity the host is spared.
The therapeutic-toxic ratio of a chemotherapeutic
agent is enhanced if and when, in addition to
engaging the attachment mechanism of the in
vader, the drug is capable also of stimulating the
body cells to the production of "receptors," or
antibodies which may be thrown into the circula
tion; the proliferation of the reticuloendothelial
cells; and the mobilization of the other phago
cytic systems of the body to offer added protection
to the host. Ehrlich’s hypothesis postulated com
plete sterilization with but a few doses. But while
interesting, this was an eventuality which, un
fortunately, actual experience failed to validate.
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The most illuminating modification of Ehrlich’s
view is that propounded by Voegtlin and Smith1
and Voegtlin, Dyer and Leonard.2 According to this
group of investigators the inactive arsenical rep
resented by the formula R— As = As— R is par
tially oxidized to form arsenoxide (R — As = 0 )
in the system and this substance as such exercises
lethal effects on the parasites. Subsequently, these
and numerous other investigators have found that
in the presence of the new chemical the defense
mechanisms of the body are apt to be markedly
increased, c.f., Cooper and Tatum.3 W ith varia
tions in specific emphases these modifications lie
back of all modern approaches to problems in
chemotherapy. The added features seem to serve
as the determinative factors differentiating a
chemotherapeutic from an antiseptic agent.
The history of the preparation of the sulfona
mides dates as far back as thirty-five years in spite
of the fact that their definitive utilization as
chemotherapeutic agents is but a matter of a few
years. Regarding their preparation Goodman and
Gilman4 state: "In 1909, Hoerlein and coworkers,
of the I.G. Farbenindustrie, synthesized the first
azo dyestuffs containing sulfonamide and substi
tuted sulfonamide groups and noted them to be
superior in color-fastness to similar dyes without
the sulfonamide group. The firm combination
which the complex azo dyes formed with the pro
teins of wool and silk suggested the possibility
that these agents might react with bacterial proto
plasm, and in 1913 Eisenberg discovered the
bactericidal action in vitro of chrysoidine and
suggested its use in chemotherapy. In the follow
ing year, Tchichibabin and Zeide (1914) synthe
sized a red dye, pyridium, from chrysoidin, which
subsequently was to be introduced as a urinary
antiseptic (Ostromyslensky, 1926). In the years
immediately following, scarlet red, another azo
dye, came into prominence and chemical advances
in the synthesis of azo dye derivatives of cupreines
were made by Jacobs and Heidelberger (1917)
and Heidelberger and Jacobs (1 9 1 9 ). The same
investigators also prepared para amino benzene
sulfonamide according to the method of Gelmo
and postulated that this substance would be lib
erated by the breakdown in the tissues of sulfonamido chrysoidin. Although they commented on
the high bactericidal potency of their compounds,
unfortunately the work was not continued. In
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1930, another azo compound known as serenium
(2 — 4 diamino 4— ethoxy azo benzene) was intro
duced by Ostromyslensky as a urinary antiseptic.”
In his attempt at clarifying the conceptual differ
ence between antisepsis and chemotherapy, Rene
Dubos3 states: "It appears that the typical anti
septic behaves as a gross protoplasmic poison de
stroying the general . . . cellular mechanisms. On
the contrary, most chemotherapeutic agents have
a very selective effect on some specific metabolic
steps.”
In this report we shall consider two of the more
recent groups of chemotherapeutic agents. Illus
trative of drugs belonging in the first category are
the sulfonamides of which prontosil, neo-prontosil, sulfanilamide, sulfapyridine, sulfathiazole, sul
fadiazine, sulfaguanadine, succynil sulfathiazole
(sulfasuccidine) and sulfamerizine are types;
while illustrative of drugs belonging in the second
category are penicillin and various other metabo
lites or so-called antibiotics extracted from bacteria,
fungi and other biological material. The chief rep
resentatives of the group are penicillin, gramicidin,
tyrocidin, tyrothricin, actinomycin, proactinomy
cin, citrinin, streptothricin, gliotoxin, fumigacin,
clavicin, lactonin, and lysozyme.
In 1933 Foerster6 administered prontosil to an
infant suffering with streptococcic septicemia and
experienced a dramatic cure. However, it was not
until 1935 that Domagk7 proposed the introduc
tion of prontosil and prontosil soluble into clinical
medicine. In the body these dyes break down to
para amino benzene sulfonamide which latter sub
stance was found by the Trefouels, Nitti and
Bovet8 to constitute their active principle. Then
it was that Fourneau9 and his associates at the
Pasteur Institute8 began preparing sulfanilamide
which with the other derivatives subsequently pro
duced is widely employed in clinical medicine.
Early investigtaions by Zahl, Hunter and
Cooper10 have firmly established the fact that in
varying degrees the sulfonamides confer limited
protection against the lethal action of endotoxins
of numerous gram-negative organisms in general
without interfering with their immunizing proc
esses. Specifically the sulfonamides have been em
ployed to clinical advantage in the treatment of
infections from beta-hemolytic streptococcus es
pecially in puerperal fever, erysipelas, septicemia,
meningococcic sore throat, surgical infections with
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gram-negative organisms, and also in gonococcic,
typhoid and paratyphoid and all types of Bru
cella infections. When employed with the specific
anti-serum the results in pneumococcic, meningococcic and streptococcic infections are better than
the results with either form of therapy alone. In
an investigation of this adjuvant action Long and
Bliss11 state that while the sulfonamide drugs pre
vent the growth and spread of the invading micro
organism, the serum neutralizes the toxic products
of their growth. As such they may be said to be
complimentary; in that, by restricting growth the
sulfonamides limit the quantity of toxic substances
produced and thereby help to mitigate, if not to
abort, the toxemia, fever and rash which those
toxic substances are calculated to produce.
In a report on the mechanism of action of the
sulfonamides, ^Schmelkes and his associates1- indi
cate that the efficiency of this class of compounds
increases with their increasing alkalinity from pH
values above 7 in the direction of 9. On this
point, however, there is as yet a lack of general
agreement. Cases of clinical acidosis resulting
from their employment have been reported by
numerous investigators, Long and Bliss,1*'1 Strauss
and Southworth,14 Towsley and Engelfried,ir> and
Beckman.10 This acidosis appears to be the result
of an increase in the renal excretion of sodium
and potassium due, apparently, to a loss of effi
ciency in the reabsorption capacity of the tubular
epithelium with respect to fixed bases; and associ
ated with a decrease in the carbon-dioxide com
bining power of the plasma.
Occasionally, when this acidosis remains un
compensated, there develops a definite hyperpnea.
As a consequence the proponents of this school of
thought advocate the concurrent administration of
sodium bicarbonate.
Over against this approach to the problem there
is the position taken by such investigators as Hart
mann, Perley and Barnett.17 These men hold that
in sulfonamide medication there occurs a loss of
serum carbon dioxide which results in an alkaline
shift of the serum; and the kidney seeks to correct
this imbalance by excreting an alkaline urine.
W ith this explanation hyperpnea falls in line with
the loss of serum carbon dioxide. As such, the
exhibition of a hyperventilation alkalosis should
therefore serve as a contraindication to the routine
use of sodium bicarbonate. They insist that under
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appropriate conditions the administration of so
dium bicarbonate might cause an uncompensated
alkalosis. In support of this contention Hartmann18
induced an acid excess type of acidosis by ad
ministering ammonium chloride to a normal sub
ject. But this acidosis was equilibrated by tubular
reabsorption of the urinary sodium bicarbonate.
When this was followed by the administration of
sulfanilamide the urinary excretion was not alka
line. To Hartmann18 this was convincing evidence
that tubular reabsorption of sodium bicarbonate is
elicitable when changes in the acid-base balance
demand such reabsorption. Beckman and his associ
ates10 have since then reinvestigated the problem.
Their findings are that sulfanilamide causes a loss
of sodium in the urine and a smaller loss of potas
sium but with no loss of chloride. They conclude
that sulfanilamide hyperpnea is an event second
ary and complimentary to depletion of plasma
bicarbonate resulting from the loss of fixed bases
in the urine and that the associated acidosis is an
expression of the body’s alkali deficit. The dis
turbance, they say, is of only minor clinical sig
nificance and is correctible by an adequate intake
of sodium chloride. The correct electrolytic pattern
is thereby maintained and there obtains a func
tional adjustment of the renal activity.
The mechanism of action of the sulfonamides
in combination with urea is also intriguing. Tannenbert and his associates-0 have made the ob
servation that organisms rendered resistant to the
sulfonamides by para-amino benzoic acid were
again rendered susceptible when urea was given
with the sulfonamide in question; and this, even
in the presence of the chemical inhibitor. They
have found, also, that staphylococci which are
resistant to sulfathiazole have showed suscepti
bility to a combination of sulfathiazole and urea.
The action of urea in this connection is not dis
similar to that of azochloramid and such purine
bodies as hypo-xanthine and adenine, which, when
used in combination with the sulfonamides even in
the presence of the inhibtor render the sulfona
mide bacteriostatic. The final explanation as to
whether or not this similarity of action is based
on the same mechanism, and what the mechanism
is, is still being sought.
At the borderline between bacterium and virus
there hovers an aura of haziness regarding the
functional efficiency of the sulfonamides. The
I
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problems that arise and might arise in this area
of indefiniteness seem destined by their clarifica
tion to make for a concurrent re-classification of
the virus diseases. It has been demonstrated by
Findley21 and Jones and his coworkers22 that sulfathiazole and sulfadiazine are both effective
against the virus of lymphogranuloma venereum.
Since it is true that the sulfonamides are effective
against but a few of the virus or virus-like diseases
it has been felt that insight gained into this differ
ential effectiveness might indirectly offer some clue
to the mechanism of action of these compounds.
Accordingly Rake, Jones and Nigg23 have carried
out a series of experiments using these two sul
fonamide compounds in mouse pneumonitis. These
investigators found that sulfathiazole and sulfa
diazine are even more effective in this disease than
they are in lymphogranuloma venereum. On the
other hand neither compound has showed sig
nificant effectiveness against meningo-pneumonitis
in mice. The etiologic agents of lymphogranuloma
venereum and mouse pneumonitis are strikingly
susceptible to the sulfonamides; as also are the
agents that produce trachoma, inclusion blenorrhea and "heart-water” fever. These are classed
with the rickettsiae. But most of the other virus
agents are not so classified today. Meanwhile, evi
dence is accumulating which tends to separate the
lymphogranuloma venereum-psitticosis group from
the true virus diseases. All investigations thus far
have failed to establish any effectiveness of the
sulfonamides against the true viruses.
THE PENICILLIN GROUP

The mould penicillium notatum produces a sub
stance which exerts a powerful inhibitive action
against gram-positive bacteria, both rods and cocci.
In vitro experiments have occasionally demon
strated such action in dilutions as weak as one in
one billion. Streptococci are inhibited in dilutions
of 1:25,000,000 and some preparations of pencillin have exhibited activity, according to Bloomfield,
Rantz and Kirby24 in dilutions of 1:100,000,000.
Against gram-negative cocci inhibitive action is
also demonstrable but only in considerably higher
strengths, 1:1,000 for instance. Anaerobic organ
isms, also, and even the treponema pallidum show
varying degrees of susceptibility to penicillin.
Powell and Jamieson25 found this antibiotic an
effective agent against sulfonamide-fast pneumo
I
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cocci in mice, and Dawson and Hobby26 speak for
its efficacy, clinically, in patients who show a pro
hibiting sensitivity to sulfonamide therapy, and
also in patients with marked renal insufficiency
and secondary anemia, in both of which conditions
the sulfonamides are usually contraindicated. For
staphylococcic infections penicillin is a happy dis
covery in that while being remarkably refractory
to the sulfonamides the organism is highly sen
sitive to penicillin. A therapeutic agent of such
high and wide effectiveness must, of necessity,
arouse intense toxicological interest since, as is
not infrequently the case with very active agents,
the therapeutic-toxic coefficient is sometimes pro
hibitively narrow. In this particular respect peni
cillin represents a striking exception. Penicillin is
remarkably non-toxic to cells of animal tissues.
Summarizing many "isolated reports” Dubos5 in
dicates that it affects neither their growth nor
metabolism; and Dawson and Hobby26 supporting
the thought state that: "a variety of experimental
observations have indicated that penicillin is com
pletely devoid of toxic effects in concentrations
far beyond those necessary for therapeutic pur
poses.” In addition, these investigators point out
that: "prolonged administration has not led to the
development of any intolerance or sensitivity . . .
or cumulative effect . . . (nor has) the infecting
strain showed . . . evidence of becoming resistant
to the action of penicillin.”
On the other hand, tyrothricin, the original
crude gramicidin obtained from bacillus brevis
which yields two other active substances, grami
cidin and tyrocidin when purified, while exhibit
ing marked action against both gram-positive and
gram-negative bacteria completely inhibits the oxy
gen consumption of bovine spermatozoa and also
their motility in acid Ringer’s phosphate and
Ringer’s bicarbonate solutions. Tolerance to this
agent is readily acquired by staphylococci; and,
with tolerance, a correlevant reduction of its
therapeutic efficiency. Although tyrothricin has not
been found thus far to be toxic towards other
animal cells which have been tested yet the pres
ence of pus, serum, gram-negative bacteria in
abundance and also its own hemolytic properties
and high toxicity act as limitations to its thera
peutic applicability. On account of these peculiarites tyrothricin (and also gramicidin and tyrocidin)
will probably be restricted in their employment
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to local administration. Little-7 has reported on
the successful use of gramicidin, locally, in bovine
mastitis and infected ulcers.
Actinomycin A and B are two substances iso
lated by Waksman and Woodruff28 from A. antibioticus. Actinomycin-A is highly selective as a
bacteriostatic agent while actinomycin-B is reputed
to be largely bactericidal. Actinomycin is antago
nistic to many bacteria and fungi. However, be
cause of its rapid disappearance from the blood
stream and also its toxic action against all animal
species its therapeutic employment will no doubt
be limited. Its in vivo effects against streptococcus
hemolyticus, type-1 pneumococcus and brucella
abortus in guinea pigs are not pronounced and
late death through respiratory failure is not in
frequently elicited.
Tyrothricin and actinomycin-A inhibit fibrolysis
and plasma coagulation by beta-hemolytic strepto
coccus cultures or their supernatant fluids, Neter.29
Another antibiotic, streptothricin derived from a
soil actinomyces has been found to be active both
in vivo and in vitro in tests with brucella abortus.
Because of its low-grade toxicity for animal tis
sues this antibiotic gives promise as an effective
agent for treating brucelliasis in animals.
Another interesting antimicrobiotic is streptomyces closely related to actinomyces griseus, which
is presently being investigated. Streptomycin re
sembles streptothricin as to solubility in water, the
manner of its isolation, its reproduction in labora
tory culture; its high selectivity against gram-nega
tive organisms, and its limited toxicity to the
animal organism. The most notable differences are
in their bacteriostatic spectra and their quanti
tative action.
Lactenin and lysozyme are good samples of antimicrobic substances derived from sources some
what different from the agents mentioned above.
The former is obtained from the albumin fraction
of milk; the latter is an enzyme present in a large
variety of animal tissues, and possibly plants also.
Jones and Simms30 have attributed to lactenin
great activity against streptococci; and lysozyme,
while especially active against non-pathogens causes
lysis of many species of bacteria, according to the
report of Meyer and his co-workers.31 These work
ers indicate that its action is due to the hydrolysis
of some mucopolysaccharide which constitutes an
integral part of the structure of the susceptible
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cell. A successful attack, not necessarily upon the
cell proper but upon those agencies which as
products or components of the cell condition its
pathogenicity might turn out to be of an order
of clinical importance equal to a direct attack.
Thus Dubos5 observes: "there have been obtained
from saprophytic micro-organisms, also from leech
extract, enzymes capable of hydrolyzing the cap
sular polysaccharides of pneumococci and strepto
cocci." And he notes that whereas the viability,
metabolism or growth in vivo of these organisms
is not affected by the destruction of their cap
sules yet their removal deprives the bacteria of
their surface protection as well as their essential
pathogenicity and renders them thereby more vul
nerable to the phagocytes of the body. Of lyso
zyme, Dubos5 has this to say specifically: "Lyso
zyme attacks a chemical component so essential
to the integrity of cellular structure that it causes
lysis and death of the susceptible cells. To affect
the pathogenic career of an infectious micro-or
ganism, however, it may be sufficient to attack a
product of the micro-organism not essential to its
vital activities but of critical importance to its
pathogenicity." With such a thought in mind the
conceptual difference between an agent that is
bacteriostatic and one that is bactericidal appears
to be merely academic.
MECHANISMS OF ACTION

Our knowledge of the mode of action of the
sulfonamide group of drugs, although limited, is
yet considerably in advance of our information on
that of the penicillin group. W e shall, therefore,
begin with a consideration of the former.
The close similarity between the structural con
figurations of para aminobenzoic acid and the sul
fonamides put over against their opposing dynamic
action has served to open up the investigation
into the mechanism of sulfonamide action.
In 1942 Thomas and Dingle32 confirming the
findings of Wood33 published a report on the
"Protection of Mice against Meningococcal Infec
tion by Sulfadiazine and Inhibition of Protection
by Para aminobenzoic Acid." These investigators
found that in appropriate doses sulfadiazine furn
ishes adequate protection against a virulent strain
of Group-1 meningococcus but that this protec
tive action could be inhibited by repeated doses
of para aminobenzoic acid. Similarly Maier and
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Riley34 reported that para aminobenzoic acid is
capable of completely inhibiting the antiplasmodial effect of sulfanilamide in rhesus monkeys.
They were also emphatic in stating that para
aminobenzoic acid exerts no inhibiting action what
ever against the antimalarial effects of quinine or
atebrine. A definite antagonism was thus demon
strated between these two chemical substances.
The accepted explanation is that bacteriostasis
is brought about in sulfonamide medication
through an interference which the drug imposes
in the course of the normal metabolic processes
of the invading cells. Cells of the living bacteria
are equipped with a complex enzyme system by
means of which they undergo a series of chemical
reactions on or near their surfaces in meeting their
nutritional needs. Para aminobenzoic acid, a basic
component of the synthetic local anesthetics of
the cocaine series, appears to be necessary for the
growth of the hemolytic streptococcus. This state
ment is also true, probably, for all organisms that
show susceptibility to the action of the sulfona
mide group of compounds. When introduced into
the para aminobenzoic acid, compete with the
latter and largely replace it in the enzymatic pro
cess. By so doing they probably prevent the com
pletion of the reaction and thereby arrest the or
ganisms in their growth.
Whereas the sulfonamides interfere with bac
terial growth, penicillin seems to interfere with
cellular division at some stage in this process.
However, neither agent seems capable of arrest
ing the susceptible organisms in their other vital
functions; for both of them when given in concen
trations even considerably in excess of the optimal
for the causation of inhibition of growth and di
vision fail to cause rapid death. Moreover, after
complete inhibition of their growth and propa
gation, if these susceptible organisms are trans
ferred to an auspicious environment upon a new
culture medium they promptly revive and proceed
to grow and divide as readily as control cells. The
sulfonamides and penicillin for this reason, then,
are referred to as bacteriostatic in action. But since
they tend to spare the host by their bacteriostatic
action they are said by some workers to be also
bactericidal, especially in large doses. In fact, in
addition to this bacteriostatic effect, investigators
of high repute like Levaditi and Vaisman33 and
Domagk7 speaking for the sulfonamides have at
tributed to these compounds the capacity to stimu
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late the phagocytic powers of the body. On the
other hand such observers as Long, Bliss and
Feinstone36 would be inclined to deny them any
such action. Regarding this moot question the
opinion expressed by Marshall36 seems to be
gaining general acceptance. He says . . . 'The first
effect in the cure of an infected animal or man is
a direct action of the drug on the parasite rather
than a stimulation of defense mechanisms of the
host. Such defense mechanisms may, however, op
erate as the final stage in the chemotherapeutic
process.”
Finally, individual specificities must not be
overlooked. For example, gramicidin, tyrocidin,
tyrothricin and actinomycin, especially, are highly
toxic to certain body cells. These antibiotics will,
therefore, always be limited in their therapeutic
scope. But by contrast penicillin and, to a less ex
tent streptomycin and streptothricin will continue
to be available for wide systemic employment.
No attempt has been made to make complete
coverage of therapeutic possibilities for these two
groups of chemical compounds. However it would
be well-nigh unpardonable were we to omit the
fact that although the sulfonamides have exhibited
no action whatever against the treponema pallidum
penicillin has. Mahoney37 reporting to the Ameri
can public Health Association states that as a re
sult of penicillin treatment there was a rapid dis
appearance of the spirochete from superficial le
sions and also the resolution of early lesions. This
observation has been verified by Bloomfield, Rantz
and Kirby24 who add that "condylomas have be
come free of treponemes in approximately twelve
to twenty hours” and that "immediate results com
parable to those obtained with full doses of arsphenamine can be achieved.” Treatment for syphi
lis with penicillin is now being undertaken under
the supervision of committees of the National Re
search Council and the Committee on Medical Re
search of the Office of Scientific Research and D e
velopment. The final verdict regarding the ques
tion of its permanent addition to the current anti
syphilitic armamentarium lies in the Jap of time.
The most interesting features which this study
into the chemotherapy of the sulfonamides and
the penicillin group of compounds reveals are the
scope of their therapeutic applicability; their spar
ing action on the cells and tissues of the host; and
their predilection for the organisms that cause in
fection. Bearing these facts in mind it seems en
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tirely within the purview of the constructive scien
tific imagination to envisage for the therapeutics
of tomorrow a mine of chemotherapeutic agents
capable of covering the entire category of patho
gens that attack and afflict the human body and
its protection against the many ailments which they
cause.
SUMMARY

1. An attempt.has been made to set forth the
differences between the essentially physical and the
essentially chemical mechanism of action of drugs.
The first category is illustrative of the action of
alkaloids, which bombard and escape unscathed and
unchanged. The second is of the glycosides which
effect molecular changes in all the affected com
ponents in the course of a typical reaction.
2. Since the problem of antisepsis is better
known than chemotherapy this knowledge of
antisepsis has been employed by way of an intro
duction to our approach to chemotherapy. Ehr
lich’s idea of chemotherapeutic agents was the e f
fecting of speedy sterilization. Since this first pro
posal, however, the truly definitive action of chemo
therapeutic agents is bacteriostasis, first; and steri
lization, later.
3. W ith this in mind the actions of two of the
newer types of chemotherapeutic agents, the sulfofiamides and the penicillin group of compounds,
has been set forth with pertinent illustrations of
their scopes and specifications.
4. The mechanisms of their action are discussed
and illustrated. The sulfonamides seem to retard
growth; penicillin group to inhibit cell division.
5. On the basis of their therapeutic range; the
ability of most of them to act on the invader while
sparing the host; and their remarkable antagon
ism with respect to infectious micro-organisms, the
warfare against infectious diseases looks bright.
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